DePuy Pinnacle Lawsuits Continue to Mount, as Federal Claims Exceed 4,400, Bernstein Liebhard LLP Reports


New York, NY (PRWEB) July 03, 2013

DePuy Pinnacle lawsuit claims involving an all-metal version of the DePuy Pinnacle Hip Replacement Program continue to mount in the federal multidistrict litigation underway in U.S. District Court, Northern District of Texas, Bernstein Liebhard LLP reports. According to a Master Case List issued by the Court on July 1, 2013, 4,445 DePuy Pinnacle hip replacement lawsuits were pending in the proceeding as of June 30th. (In re: DePuy Orthopaedics Inc. Pinnacle Hip Implant Product Liability Litigation, MDL No. 2244 N.D. Texas)

&#13

Our Firm continues to receive inquiries from individuals who have suffered metallosis, premature device failure and other serious complications allegedly related with the metal-on-metal DePuy Pinnacle hip replacement. We anticipate that filings in this litigation will continue to increase in the coming months, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and health-related devices. Jeffrey S. Grand, a companion with Bernstein Liebhard LLP, serves on the Plaintiffs Steering Committee for the federal litigation, while the Firms DePuy Pinnacle lawyers continue to offer you cost-free legal evaluations to alleged victims of severe complications connected with the all-metal DePuy Pinnacle Hip Replacement Method.

&#13

DePuy Pinnacle Hip Replacement Lawsuits&#13

All of the DePuy Pinnacle hip replacement lawsuits pending in the Northern District of Texas involve a version of the Pinnacle hip method that utilized the Ultamet liner. According to court documents, plaintiffs allege that they have suffered premature implant failure, metallosis and other serious complications due to the propensity of the device to shed dangerous amounts of metal ions into the tissue surrounding the implant, as effectively as the blood stream. The lawsuits further allege that the all-metal Pinnacle shares some of the same style flaws that prompted DePuy Orthopaedics to recall its ASR line of metal hip implants in 2010, and question no matter whether this version of Pinnacle program must have been recalled as properly.

&#13

Even though it does not seem that a DePuy Pinnacle recall is imminent, DePuy Orthopaedics did announce in May possibly that it would be ending sales of all-metal hips, which includes the metal-on-metal Pinnacle. While the firm did not cite the increasing number of DePuy Pinnacle hip replacement lawsuits as a contributing issue to this selection, it did note that demand for metal-on-metal hips has slipped in recent years. According to a May 17th report from The New York Occasions, DePuy also cited a proposed regulation from the U.S. Food &amp Drug Administration (FDA) that would demand the producers of metal-on-metal hips at the moment on the industry to conduct post-marketplace safety research in order to preserve promoting the goods.*

&#13

Victims of significant complications allegedly associated with the metal-on-metal DePuy Pinnacle hip implant may possibly be entitled to compensation for their healthcare care, discomfort and suffering, and other damages. Added details about filing a DePuy Pinnacle hip replacement lawsuit is offered at Bernstein Liebhards site. For a free, no obligation legal consultation with a DePuy Pinnacle lawyer, please call 800-511-5092 today.

&#13

*nytimes.com/2013/05/17/company/jj-is-phasing-out-metal-replacement-hips.html?ref=health&amp_r=

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide since 1993, which includes these who have been harmed by dangerous drugs, defective health-related devices and customer goods. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the best plaintiffs firms in the nation, for the past ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Advertising.

Biomet Hip Lawsuits Mount in Federal Biomet M2a Magnum Hip Replacement Litigation, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) June 16, 2013

Biomet hip lawsuit claims alleging severe injuries due to the Biomet M2a Magnum Hip Replacement Technique continue to mount in a federal multidistrict litigation underway in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to an MDL Statistics Report issued on May possibly 14th by the U.S. Judicial Panel on Multidistrict Litigation (JPML), at least 308 Biomet hip replacement claims have been filed in the federal litigation given that it was established in October 2012. (In re: Biomet M2a Magnum Hip Implant Goods Liability Litigation MDL No. 2391)

&#13

We continue to hear from people fitted with metal-on-metal hip implants, including the Biomet M2a Magnum, who allegedly suffered significant complications linked with the failure of their device. It is not surprising that the number of Biomet hip replacement lawsuits filed in this litigation has currently surpassed 300, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and healthcare devices. The Firm is actively filing Biomet hip lawsuits in the federal multidistrict litigation, and continues to supply totally free and confidential case evaluations to men and women who might have been injured by Biomet M2a Magnum implants.

&#13

Biomet Hip Replacement Lawsuits&#13

According to court documents, Biomet hip lawsuits allege the metal-on-metal style of the Biomet M2a Magnum implant is prone to put on, and can create higher metal ion levels. This could trigger sufferers to endure metallosis and other adverse tissue reactions, premature device failure and other complications that necessitate revision surgery to get rid of and replace the device. When the multidistrict litigation was established by the JPML in October 2011, 66 Biomet hip replacement claims had been pending in federal courts all through the U.S.

&#13

The U.S. Food &amp Drug Administration (FDA) has been investigating metal-on-metal hip implants because February 2011, amid concerns that metal ions shed from the hips can outcome in metallosis, adverse neighborhood tissue reactions, and early failure. In January, the agency issued new guidance for hip replacement patients fitted with these devices that suggested metal ion testing in those experiencing symptoms of hip implant failure. The FDA also mentioned it had proposed a new rule that would make all-metal hips ineligible for 510(k) approvals, a process which permitted metal-on-metal hips to come to market without having very first undergoing human clinical trials.*

&#13

Biomet M2a Magnum hip recipients who allegedly suffered injuries as a result of the device might be entitled to compensation for their healthcare expenses, lost wages and discomfort and suffering. To understand a lot more about the litigation surrounding this and other metal-on-metal hip implants, please visit Bernstein Liebhard LLPs site, or get in touch with 1 our attorneys today at 800-511-5092.

&#13

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide because 1993, such as those who have been harmed by hazardous drugs, defective healthcare devices and consumer goods. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the best plaintiffs firms in the nation, for the past 10 consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Marketing.

Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) May 25, 2013

Pradaxa lawsuits filed on behalf of patients who allegedly suffered serious, life-threatening episodes of internal bleeding while using the blood thinner continue to mount in a federal litigation underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to a posting on the Courts website, 818 Pradaxa side effect claims had been filed in the litigation as of May 24, 2013. Thats up from 705 claims reported by the Court on May 15th. ( In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation MDL No. 2385)

We are not surprised that the Pradaxa lawsuits filed in this litigation are increasing at such a rapid rate. Our Firm receives inquiries on a regular basis from Pradaxa patients who have allegedly suffered serious instances of internal bleeding, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free Pradaxa side effect lawsuit evaluations to anyone who suffered internal bleeding while using the blood thinner.

Pradaxa Side Effects

Plaintiffs with claims pending in the Pradaxa side effect litigation allege that Boehringer Ingelheim failed to adequately warn that there is no readily-available antidote for internal bleeding that is sometimes associated with use of the blood thinner. According to a Bloomberg.com report published in December 2012, regulators in several countries have issued alerts regarding Pradaxas potential to cause dangerous internal bleeding in some patients.* Pradaxa was supposed to be an improvement over warfarin, a decades old blood thinner. However, warfarin bleeding can be stopped via the administration of vitamin K, while dialysis is the only available treatment for this Pradaxa side effect.